NCas9 Engineering for Improved Target Interaction Presents an Effective Strategy to Enhance Base Editing
Overview
Authors
Affiliations
Base editors (BEs) are a recent generation of genome editing tools that couple a cytidine or adenosine deaminase activity to a catalytically impaired Cas9 moiety (nCas9) to enable specific base conversions at the targeted genomic loci. Given their strong application potential, BEs are under active developments toward greater levels of efficiency and safety. Here, a previously overlooked nCas9-centric strategy is explored for enhancement of BE. Based on a cytosine BE (CBE), 20 point mutations associated with nCas9-target interaction are tested. Subsequently, from the initial positive X-to-arginine hits, combinatorial modifications are applied to establish further enhanced CBE variants (1.1-1.3). Parallel nCas9 modifications in other versions of CBEs including A3A-Y130F-BE4max, YEE-BE4max, CGBE, and split-AncBE4max, as well as in the context of two adenine BEs (ABE), likewise enhance their respective activities. The same strategy also substantially improves the efficiencies of high-fidelity nCas9/BEs. Further evidence confirms that the stabilization of nCas9-substrate interactions underlies the enhanced BE activities. In support of their translational potential, the engineered CBE and ABE variants respectively enable 82% and 25% higher rates of editing than the controls in primary human T-cells. This study thus demonstrates a highly adaptable strategy for enhancing BE, and for optimizing other forms of Cas9-derived tools.
Enhanced Genome Editing Activity with Novel Chimeric ScCas9 Variants in Rice.
Liang Z, Wu Y, Deng S, Wei S, Zhang K, Guo Y Adv Sci (Weinh). 2025; 12(8):e2411549.
PMID: 39755933 PMC: 11848528. DOI: 10.1002/advs.202411549.
Research Progress and Application of Miniature CRISPR-Cas12 System in Gene Editing.
Xuan Q, Wang J, Nie Y, Fang C, Liang W Int J Mol Sci. 2024; 25(23).
PMID: 39684395 PMC: 11641405. DOI: 10.3390/ijms252312686.
Strategies for improving the genome-editing efficiency of class 2 CRISPR/Cas system.
Wang L, Han H Heliyon. 2024; 10(19):e38588.
PMID: 39397905 PMC: 11471210. DOI: 10.1016/j.heliyon.2024.e38588.
Zhang G, Song Z, Huang S, Wang Y, Sun J, Qiao L Adv Sci (Weinh). 2024; 11(31):e2405426.
PMID: 38881503 PMC: 11336945. DOI: 10.1002/advs.202405426.